Profile picture

Doctor Spyridon Maragkoudakis

General Hospital St. George, Chania (Greece)
Membership: ESC Professional Member EAPC Member HFA Member
Follow
Logo ESC

Contributor content

The potential protective effect of dapagliflozin  on the development of cardiotoxicity in cancer patients after two years of observation.
Presentation
The potential protective effect of dapagliflozin on the development of cardiotoxicity in cancer patients after two years of observation.
The potential protective effect of dapagliflozin  on the development of cardiotoxicity in cancer patients after one year of observation.
Presentation
The potential protective effect of dapagliflozin on the development of cardiotoxicity in cancer patients after one year of observation.
The potentially protective effect of dapagliflozin  on the development of cardiotoxicity in cancer patients
Presentation
The potentially protective effect of dapagliflozin on the development of cardiotoxicity in cancer patients

ESC 365 is supported by